|
|
|
|
| LEADER |
05339nmm a2200409 u 4500 |
| 001 |
EB000673720 |
| 003 |
EBX01000000000000000526802 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642770746
|
| 100 |
1 |
|
|a Pagel, Horst
|e [editor]
|
| 245 |
0 |
0 |
|a Pathophysiology and Pharmacology of Erythropoietin
|h Elektronische Ressource
|c edited by Horst Pagel, Christoph Weiss, Wolfgang Jelkmann
|
| 250 |
|
|
|a 1st ed. 1992
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1992, 1992
|
| 300 |
|
|
|a XVI, 328 p
|b online resource
|
| 505 |
0 |
|
|a List of Contents -- I. Structure and Action -- Structure-Function Relationships of Erythropoietin -- Isoforms of Recombinant Human Erythropoietin -- Activation of the Erythropoietin Receptor in the T3C12 Friend Erythroleukemia Cell Line -- II. Sites and Control of Production -- The Role of Adenosine in Hypoxic Regulation of Kidney Production of Erythropoietin -- Oxygen Shunt Diffusion in Renal Cortex and Its Physiological Link to Erythropoietin Production -- Oxygen Sensing and Erythropoietin mRNA Production in Isolated Perfused Rat Kidneys -- Analysis of Erythropoietin Gene Expression by Means of Competitive Polymerase Chain Reaction -- The Developmental Biology of Erythropoiesis and Erythropoietin: Is Erythropoietin a True Hormone or a Paracrine Factor -- Insulin-like Growth Factor 1 and Erythropoiesis During Growth -- III. Blood Levels in Health and Disease -- Clinical Applicability of the Determination of Erythropoietin --
|
| 505 |
0 |
|
|a The Effect of Erythropoietin in Chemotherapy-Induced Anaemia in Patients with Osteosarcoma and Ewing’s Sarcoma -- Erythropoietin in Bone Marrow Transplantation: Pathophysiology and Clinical Use -- Experimental and Clinical Results of Perioperative Treatment with Recombinant Human Erythropoietin
|
| 505 |
0 |
|
|a Cardiological Findings in Patients with End-Stage Renal Failure Under Treatment with Erythropoietin -- Long-Term Treatment with Recombinant Human Erythropoietin in Haemodialysis Patients: Effects on Left Ventricular Performance -- Retinal Hypoxia and Anemia in Chronic Renal Failure: Effect of Erythropoietin -- Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients -- Pharmacodynamic Aspects of Recombinant Human Erythropoietin - Long-Term Results in Patients with Hemodialysis Treatment -- Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells -- Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin -- V. Primary Hemopoietic Disorders and Chemotherapy -- Serum Erythropoietin Levels in Aplastic Anemia Determined by ELISA -- Serum Erythropoietin in Myelodysplasia Syndromes --
|
| 505 |
0 |
|
|a Antigenic Characteristics of Erythropoietin-Dependent and -Independent Erythroid Progenitors in Chronic Myeloproliferative Disorders Defined by Monoclonal Antibodies -- Chemotherapy and Erythropoietin Production -- Production of Erythropoietin During and After Thiamphenicol Treatment Occurs Independently of Peripheral Blood Cell Numbers -- VI. Application of Recombinant Erythropoietin in Non-Renal Anemia -- Effects of Inflammatory Cytokines on the Production of Erythropoietin -- The Use of Recombinant Human Erythropoietin in the Treatment of the Anemia of Chronic Disorders -- Recombinant Human Erythropoietin in the Treatment of Anaemia in Rheumatoid Arthritis -- Erythropoietin in Neoplastic Diseases: Preliminary Results -- Erythropoietin Effects on Acute Anemia Induced by Antineoplastic Therapy in the Case of a Uremic Patient with Lymphoma -- The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplasia Syndromes --
|
| 505 |
0 |
|
|a A Sensitive ELISA for Erythropoietin and Its Application in Various Diseases -- Use of Erythropoietin Radioimmunoassay in Polycythemias -- Effects of Exercise on Plasma Erythropoietin in Natives Living Permanently at High Altitude -- Erythropoietin Concentration in Renal Venous Blood in Patient with Renovascular Hypertension: Is It a Marker of Renal Ischemia -- Serum Erythropoietin Levels in Von Hippel-Lindau Syndrome -- IV. Erythropoietin Replacement in Renal Failure -- Iron Metabolism Under Treatment of Renal Anemia with Recombinant Human Erythropoietin -- Erythropoietin Treatment in Children with Renal Anemia -- Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1, 25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies -- Dyserythropoietic Abnormalities in Hemodialysis Patients on Long-Term Therapy with Human Recombinant Erythropoietin --
|
| 653 |
|
|
|a Hematology
|
| 653 |
|
|
|a Human Physiology
|
| 653 |
|
|
|a Nephrology
|
| 653 |
|
|
|a Nephrology
|
| 653 |
|
|
|a Hematology
|
| 653 |
|
|
|a Human physiology
|
| 653 |
|
|
|a Pediatrics
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Pediatrics
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 700 |
1 |
|
|a Weiss, Christoph
|e [editor]
|
| 700 |
1 |
|
|a Jelkmann, Wolfgang
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-77074-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 612
|